Arguments against mammography screening continue to be based on faulty science

Oncologist

Volumn 19, Issue 2, 2014, Pages 107-112

  Kopans, Daniel B ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BIOPSY NEEDLE; BREAST CANCER; CANCER SCREENING; FEMALE; FOLLOW UP; HUMAN; LOCAL ANESTHESIA; MAMMOGRAPHY; NEOPLASM; PHYSICIAN; PREVALENCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); BREAST NEOPLASMS; EARLY DIAGNOSIS; MIDDLE AGED; MORTALITY; PROCEDURES; RADIOGRAPHY; STANDARDS;

BREAST NEOPLASMS; EARLY DETECTION OF CANCER; FEMALE; HUMANS; MAMMOGRAPHY; MIDDLE AGED; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84894094693     PISSN: 10837159     EISSN: 1549490X     Source Type: Journal    
DOI: 10.1634/theoncologist.2013-0184     Document Type: Article

References (55)

1. Kopans DB, Halpern E, Hulka CA. Statistical powerin breast cancer screening trialsand mortality reduction among women 40-49 years of age with particular emphasis on the National Breast Screening Study of Canada. Cancer 1994;74:1196-1203.
2. Hendrick RE, Smith RA, Rutledge JH 3rd et al. Benefit of screening mammography in women aged 40-49: A new meta-analysis of randomized controlled trials. J Natl Cancer Inst Monogr 1997;22: 87-92.
3. Kopans DB, Moore RH, McCarthy KA et al. Biasing the interpretation ofmammographyscreening data by age grouping: Nothing changes abruptly at age 50. Breast J 1998;4:139-145.
4. Shapiro S. Evidence on screening for breast cancer from a randomized trial. Cancer 1977;39 (Suppl):2772-2782.
5. Kopans DB. The 2009 U.S. Preventive Services Task Force guidelines ignore important scientific evidence and should be revised or withdrawn. Radiology 2010;256:15-20.
6. Mandelblatt JS, Cronin KA, Bailey S et al; Breast Cancer Working Group of the Cancer Intervention and Surveillance Modeling Network. Effects of mammography screening under different screening schedules: Model estimates of potential benefits and harms. Ann Intern Med 2009;151:738-747.
7. Hendrick RE, Helvie MA. United States Preventive Services Task Force screening mammography recommendations: Science ignored. AJR Am J Roentgenol 2011;196:W112-W116.
8. Screening mammography in women aged 40-49: A report of the American College of Physicians and American College of Radiology consensus meeting. Available at http://www.acpinternist.org/archives/ 2012/05/policy.htm. Accessed September 9. 2012.
9. Spivey GH, Perry BW, Clark VA et al. Predicting the risk of cancer at the time of breast biopsy. Variation in the benign to malignant ratio. Am Surg 1982;48:326-332.
10. Gøtzsche PC. Time to stop mammography screening? CMAJ 2011;183:1957-1958.
11. Zahl PH, Maehlen J, Welch HG. The natural history of invasive breast cancers detected by screening mammography. Arch Intern Med 2008; 168:2311-2316.
12. Autier P, Boniol M, Gavin A et al. Breast cancer mortality in neighbouring European countries with different levels of screening but similar access to treatment: Trend analysis of WHO mortality database. BMJ 2011;343:d4411.
13. Jørgensen KJ, Gøtzsche PC. Overdiagnosis in publicly organised mammography screening programmes: Systematic review of incidence trends. BMJ 2009;339:b2587.
14. Bock K, Borisch B, Cawson J et al. Effect of population-based screening on breast cancer mortality. Lancet 2011;378:1775-1776.
15. Kalager M, Zelen M, Langmark F et al. Effect of screening mammography on breast-cancer mortality in Norway. N Engl J Med 2010;363:1203-1210.
16. Lynge E, Braaten T, Njor SH et al. Mammography activity in Norway 1983 to 2008. Acta Oncol 2011;50:1062-1067.
17. Kopans DB. Screening for breast cancer and mortality reduction among women 40-49 years of age. Cancer 1994;74(Suppl):311-322.
18. Tabár L, Vitak B, Chen TH et al. Swedish twocounty trial: Impact of mammographic screening on breast cancer mortality during 3 decades. Radiology 2011;260:658-663.
19. Hofvind S, Ursin G, Tretli S et al. Breast cancer mortality in participants of the Norwegian Breast Cancer Screening Program. Cancer 2013;119: 3106-3112.
20. Tabár L, Vitak B, Chen HH et al. Beyond randomized controlled trials: organized mammographic screening substantially reduces breast carcinoma mortality. Cancer 2001;91:1724-1731.
21. DuffySW, Tabár L, Chen HH et al. The impact of organized mammography service screening on breast carcinoma mortality in seven Swedish counties. Cancer 2002;95:458-469.
22. Otto SJ, Fracheboud J, Looman CWN et al; National Evaluation Team for Breast Cancer Screening. Initiation of population-based mammography screening in Dutch municipalities and effect on breast-cancer mortality: a systematic review. Lancet 2003;361:1411-1417.
23. van Schoor G, Moss SM, Otten JD et al. Increasingly strong reduction in breast cancer mortality due to screening. Br J Cancer 2011;104: 910-914.
24. Otto SJ, Fracheboud J, Verbeek ALM et al; National Evaluation Team for Breast Cancer Screening. Mammography screening and risk of breast cancer death: A population-based case-control study. Cancer Epidemiol Biomarkers Prev 2012;21: 66-73.
25. Swedish Organised Service Screening Evaluation Group. Reduction in breast cancer mortality from organized service screening with mammography: 1. Further confirmation with extended data. Cancer Epidemiol Biomarkers Prev 2006;15:45-51.
26. Hellquist BN, Duffy SW, Abdsaleh S et al. Effectiveness of population-based service screening with mammography for women ages 40 to 49 years: Evaluation of the SwedishMammographyScreening in Young Women (SCRY) cohort. Cancer 2011;117: 714-722.
27. Coldman A, Phillips N, Warren L et al. Breast cancer mortality after screening mammography in British Columbia women. Int J Cancer 2007;120: 1076-1080.
28. Kopans DB. Beyond randomized controlled trials: Organized mammographic screening substantially reduces breast carcinoma mortality. Cancer 2002; 94:580-581; author reply 581-583.
29. Kopans DB, Feig SA. The Canadian National Breast Screening Study: A critical review. AJR Am J Roentgenol 1993;161:755-760.
30. Tarone RE. The excess of patients with advanced breast cancer in young women screened withmammography in the Canadian National Breast Screening Study. Cancer 1995;75:997-1003.
31. Gøtzsche PC, Olsen O. Is screening for breast cancer with mammography justifiable? Lancet 2000;355:129-134.
32. Merz B. Author of Canadian Breast Cancer Study retracts warnings. J Natl Cancer Inst 1992;84:833-834.
33. Kopans DB, Rafferty E, Georgian-Smith D et al. A simple model of breast carcinoma growth may provide explanations for observations of apparently complex phenomena. Cancer 2003;97:2951-2959.
34. Yen AM, Duffy SW, Chen TH et al. Long-term incidence of breast cancer by trial arm in one county of the Swedish Two-County Trial of mammographic screening. Cancer 2012;118:5728-5732.
35. Njor SH, Olsen AH, Blichert-Toft M et al. Overdiagnosis in screening mammography in Denmark: Population based cohort study. BMJ 2013; 346:f1064.
36. Yen MF, Tabár L, Vitak B et al. Quantifying the potential problem of overdiagnosis of ductal carcinoma in situ in breast cancer screening. Eur J Cancer 2003;39:1746-1754.
37. Kopans DB, Smith RA, Duffy SW. Mammographic screening and "overdiagnosis". Radiology 2011;260:616-620.
38. Paci E, Warwick J, Falini P et al. Overdiagnosis in screening: is the increase in breast cancer incidence rates a cause for concern? JMed Screen 2004;11:23-27.
39. Duffy SW, Agbaje O, Tabar L et al. Overdiagnosis and overtreatment of breast cancer: Estimates of overdiagnosis from two trials of mammographic screening for breast cancer. Breast Cancer Res 2005;7:258-265.
40. Puliti D, Duffy SW, Miccinesi G et al; EUROSCREENWorking Group. Overdiagnosis in mammographic screening for breast cancer in Europe: A literature review. J Med Screen 2012;19(Suppl 1): 42-56.
41. Zackrisson S, Andersson I, JanzonL et al. Rateof over-diagnosis of breast cancer 15 years after end of Malmö mammographic screening trial: Follow-up study. BMJ 2006;332:689-692.
42. Bleyer A, Welch HG. Effect of three decades of screening mammography on breast-cancer incidence. N Engl J Med 2012;367:1998-2005.
43. Garfinkel L, Boring CC, Heath CW Jr. Changing trends. An overview of breast cancer incidence and mortality. Cancer 1994;74(Suppl):222-227.
44. Use ofmammography amongwomen40 years ofageandover. Availableathttp://www.cdc.gov/nchs/ data/health_policy/mammography.pdf. Updated July 2009. Accessed April 17, 2013.
45. Use ofmammography amongwomen40 years of age and over. Available at http://www.cdc.gov/ nchs/health_policy/mammography.htm. Updated September 25, 2009. Accessed July 28, 2013.
46. Stat Fact Sheets SEER. Breast. Available at http://seer.cancer.gov/statfacts/html/breast.html. Accessed March 23, 2013.
47. Bleyer A, Welch HG. Effect of screening mammography on breast cancer incidence. N Engl JMed 2013;368:679.
48. American Cancer Society. Breast cancer facts& figures 2007-2008. Atlanta, GA: American Cancer Society, 2007:9.
49. Smith RA, Duffy SW, Gabe R et al. The randomized trials of breast cancer screening: What have we learned? Radiol Clin North Am 2004;42: 793-806, v.
50. Connor RJ, Chu KC, Smart CR. Stage-shift cancer screening model. J Clin Epidemiol 1989;42: 1083-1095.
51. Ernster VL, Barclay J, Kerlikowske K et al. Incidence of and treatment for ductal carcinoma in situ of the breast. JAMA 1996;275: 913-918.
52. Save your life: cancer screening is oversold. Know the tests to get-and those to skip. Consum Rep 2013;78:28-33.
53. Welch HG. If you feel O.K., maybe you are O.K. Available at http://www.nytimes.com/2012/02/28/ opinion/overdiagnosis-as-a-flaw-in-health-care. html?_r50.
54. Orenstein P. Our feel-good war on breast cancer. Available at http://www.nytimes.com/ 2013/04/28/magazine/our-feel-good-war-on-breastcancer. html?pagewanted5all. Accessed April 29, 2013.
55. Skolnik D. Go ahead, blow it off! 6 Health rules you can break. Available at http://www.lhj. com/health/news/blow-it-off-6-health-rulesyou-can-break/?page52. Accessed August 20, 2013.